Hoth Therapeutics has deployed the OpenAI API to support IND-enabling development of HT-KIT, its orphan-designated therapy targeting KIT-driven cancers.

Moderna has entered into a settlement agreement resolving all worldwide Arbutus Biopharma Corporation/Genevant Sciences GmbH ...

A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.

Latigo Biotherapeutics is appointing Neha Krishnamohan as both Chief Financial Officer (CFO) and Chief Business Officer (CBO) ...

Kivu Bioscience is naming Brunilda Shtylla Chief Business Officer, with Shtylla assuming the same role she held at Sutro Biopharma.

Discover the transformation of antibody-drug conjugates (ADCs) from experimental to essential in cancer therapy with new ...

BostonGene and Unilever are starting a strategic collaboration in scientific exploration and long-term innovation.

Regulatory momentum, device innovation, and advances in formulation science are repositioning the nasal route as a strategic option for systemic and CNS therapies—provided sponsors address ...

Xmoor Pharma has appointed Manuel Balbuena as Chief Commercial Officer as the company continues to build its position as an integrated cell and gene therapy CDMO, supporting clients across complex and ...

Forge Biologics will provide process development and manufacturing services to support gene therapy for ultrarare disease Progeria ...

BioDuro, a CRDMO, has established a joint venture with Cenra API Solutions, a pharmaceutical chemical manufacturer in Taiwan.

CellCarta, a global CRO laboratory to the biopharmaceutical industry, has appointed Ehab A. El-Gabry, MD, as Chief Medical ...